Legacy Private Trust’s Neumora Therapeutics NMRA Stock Holding History

Legacy Private Trust’s Portfolio NMRA Stock Details NMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14.9K	Hold	25,000	–	–	﹤0.01%	270
2026 Q2	$42.5K	Buy	25,000 +6,000	+32%	+$11.4K	﹤0.01%	265
2026 Q1	$37K	Hold	19,000	–	–	﹤0.01%	259
2025 Q4	$34K	Buy	19,000 +5,000	+36%	+$10.9K	﹤0.01%	257
2025 Q3	$25.5K	Buy	+14,000	New	+$22.6K	﹤0.01%	256
2025 Q2	–	Sell	-12,000	Closed	-$12K	–	253
2025 Q1	$12K	Buy	12,000 +2,000	+20%	+$3.42K	﹤0.01%	243
2024 Q4	$106K	Hold	10,000	–	–	0.01%	235
2024 Q3	$132K	Hold	10,000	–	–	0.01%	230
2024 Q2	$98.3K	Hold	10,000	–	–	0.01%	226
2024 Q1	$138K	Hold	10,000	–	–	0.01%	225
2023 Q4	$171K	Buy	+10,000	New	+$123K	0.01%	219

Other funds holding NMRA

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Legacy Private Trust's NMRA Position: Q3 2026 in Review

Legacy Private Trust held its Neumora Therapeutics (NMRA) position steady in Q3 2026 at 25,000 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #270.

Legacy Private Trust first reported a position in NMRA in Q4 2023 and has held it in 11 quarters since. The position peaked at $171K in Q4 2023. 6 funds tracked by Wall St. Rank hold NMRA as of Q3 2026.

Legacy Private Trust held 25,000 shares of Neumora Therapeutics worth $14.9K as of Q3 2026.
Legacy Private Trust left its Neumora Therapeutics share count unchanged in Q3 2026.
Neumora Therapeutics made up ﹤0.01% of Legacy Private Trust's portfolio in Q3 2026, its #270 holding.
Legacy Private Trust first reported a position in Neumora Therapeutics in Q4 2023 and has held it in 11 quarters since.
Legacy Private Trust's Neumora Therapeutics position peaked at $171K in Q4 2023.
6 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q3 2026.

Based on Legacy Private Trust's 13F filing for Q3 2026, filed 6 Oct 2026.